JP2021524480A5 - - Google Patents

Info

Publication number
JP2021524480A5
JP2021524480A5 JP2021500106A JP2021500106A JP2021524480A5 JP 2021524480 A5 JP2021524480 A5 JP 2021524480A5 JP 2021500106 A JP2021500106 A JP 2021500106A JP 2021500106 A JP2021500106 A JP 2021500106A JP 2021524480 A5 JP2021524480 A5 JP 2021524480A5
Authority
JP
Japan
Prior art keywords
group
formula
substituted
pharmaceutically acceptable
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021500106A
Other languages
English (en)
Japanese (ja)
Other versions
JP7541302B2 (ja
JP2021524480A (ja
Filing date
Publication date
Priority claimed from EP18305911.2A external-priority patent/EP3594205A1/en
Application filed filed Critical
Publication of JP2021524480A publication Critical patent/JP2021524480A/ja
Publication of JP2021524480A5 publication Critical patent/JP2021524480A5/ja
Application granted granted Critical
Publication of JP7541302B2 publication Critical patent/JP7541302B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021500106A 2018-07-09 2019-07-09 Rnaウィルス感染を処置する為のアリール-n-アリール誘導体 Active JP7541302B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18305911.2 2018-07-09
EP18305911.2A EP3594205A1 (en) 2018-07-09 2018-07-09 Phenyl-n-aryl derivatives for treating a rna virus infection
PCT/EP2019/068460 WO2020011811A1 (en) 2018-07-09 2019-07-09 Aryl-n-aryl derivatives for treating a rna virus infection

Publications (3)

Publication Number Publication Date
JP2021524480A JP2021524480A (ja) 2021-09-13
JP2021524480A5 true JP2021524480A5 (enExample) 2022-06-22
JP7541302B2 JP7541302B2 (ja) 2024-08-28

Family

ID=63035967

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2021500106A Active JP7541302B2 (ja) 2018-07-09 2019-07-09 Rnaウィルス感染を処置する為のアリール-n-アリール誘導体
JP2021500268A Active JP7491513B2 (ja) 2018-07-09 2019-07-09 Rnaウィルス感染を処置する為のアリール-n-アリール誘導体
JP2021500577A Active JP7634847B2 (ja) 2018-07-09 2019-07-09 Rnaウィルス感染を処置する為のアリール-n-アリール誘導体

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2021500268A Active JP7491513B2 (ja) 2018-07-09 2019-07-09 Rnaウィルス感染を処置する為のアリール-n-アリール誘導体
JP2021500577A Active JP7634847B2 (ja) 2018-07-09 2019-07-09 Rnaウィルス感染を処置する為のアリール-n-アリール誘導体

Country Status (23)

Country Link
US (3) US12247018B2 (enExample)
EP (4) EP3594205A1 (enExample)
JP (3) JP7541302B2 (enExample)
KR (3) KR102905375B1 (enExample)
CN (3) CN112703183B (enExample)
AU (3) AU2019300102B2 (enExample)
BR (3) BR112021000336A2 (enExample)
CA (3) CA3104228A1 (enExample)
CU (3) CU24667B1 (enExample)
CY (1) CY1126466T1 (enExample)
DK (1) DK3820849T3 (enExample)
ES (1) ES2965067T3 (enExample)
FI (1) FI3820849T3 (enExample)
HR (1) HRP20231571T1 (enExample)
HU (1) HUE064304T2 (enExample)
LT (1) LT3820849T (enExample)
MX (3) MX2021000090A (enExample)
PL (1) PL3820849T3 (enExample)
PT (1) PT3820849T (enExample)
RS (1) RS64949B1 (enExample)
SI (1) SI3820849T1 (enExample)
WO (3) WO2020011812A1 (enExample)
ZA (3) ZA202100142B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018165520A1 (en) 2017-03-10 2018-09-13 Vps-3, Inc. Metalloenzyme inhibitor compounds
PL3999493T3 (pl) * 2019-07-19 2024-04-22 Abivax Pochodne arylo-N-arylowe do leczenia zakażenia wirusem RNA
WO2021021979A2 (en) 2019-07-30 2021-02-04 Eikonizo Therapapeutics, Inc. Hdac6 inhibitors and uses thereof
EP4125845A4 (en) * 2020-04-02 2024-05-15 Southern Research Institute NEW 2-PYRIMIDONE ANALOGUES AS EFFECTIVE ANTIVIRAL AGENTS AGAINST ALPHAVIRES
CN115417834B (zh) * 2020-11-24 2024-06-11 中国人民解放军海军军医大学 一类取代苯甲酰哌嗪类化合物及在制备抗基孔肯雅病毒药物中的应用
JP2024506858A (ja) 2021-02-02 2024-02-15 リミナル・バイオサイエンシーズ・リミテッド Gpr84アンタゴニストおよびその使用
KR20230153387A (ko) 2021-02-02 2023-11-06 리미널 바이오사이언시스 리미티드 Gpr84 길항제 및 이의 용도
WO2022195522A1 (en) * 2021-03-17 2022-09-22 Ildong Pharmaceutical Co., Ltd. Inhibitors of ano6 and their uses thereof
EP4504190A4 (en) 2022-04-08 2026-03-25 Eikonizo Therapeutics Inc OXADIAZOLE HDAC6 INHIBITORS AND THEIR USES

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070244120A1 (en) * 2000-08-18 2007-10-18 Jacques Dumas Inhibition of raf kinase using substituted heterocyclic ureas
US7429599B2 (en) * 2000-12-06 2008-09-30 Signal Pharmaceuticals, Llc Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK
FR2830862A1 (fr) 2001-10-16 2003-04-18 Lipha Derives nitroso de la diphenylamine a fonction ether ou thioether, compositions pharmaceutiques les contenant et leur utilisation pour la preparation de medicaments
FR2836917B1 (fr) 2002-03-11 2006-02-24 Lipha Derives nitroso de la diphenylamine, compositions pharmaceutiques les contenant en tant que medicaments utilisables dans le traitement des pathologies caracterisees par une situation de stress oxydatif
KR20060119871A (ko) 2003-08-21 2006-11-24 오에스아이 파마슈티컬스, 인코포레이티드 N3―치환된 이미다조피리딘 c―kit 억제제
FR2859474B1 (fr) 2003-09-04 2006-01-13 Centre Nat Rech Scient Utilisation de composes derives d'indole pour la preparation d'un medicament utile pour le traitement de maladies genetiques resultant de l'alteration des processus d'epissage
TWI356055B (en) 2003-12-18 2012-01-11 Tibotec Pharm Ltd Aminobenzimidazoles and benzimidazoles as inhibito
FR2866647B1 (fr) 2004-02-20 2006-10-27 Servier Lab Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP1794135A1 (en) 2004-09-27 2007-06-13 Amgen Inc. Substituted heterocyclic compounds and methods of use
MX2007011292A (es) 2005-03-17 2007-11-07 Tibotec Pharm Ltd 1,3-dihidro-bencimidazol-2-ilidenaminas como inhibidores de replicacion de virus respiratorios sinciciales.
US9409856B2 (en) 2005-11-28 2016-08-09 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
US7915411B2 (en) 2005-12-21 2011-03-29 Abbott Laboratories Anti-viral compounds
CN101384592A (zh) 2005-12-21 2009-03-11 艾博特公司 抗病毒化合物
CN102702194A (zh) 2005-12-21 2012-10-03 雅培制药有限公司 抗病毒化合物
FR2901273B1 (fr) 2006-05-19 2010-12-24 Anaconda Pharma Inhibiteurs du virus du papillome humain et les compositions pharmaceutiques les contenant
JP4486667B2 (ja) * 2007-10-01 2010-06-23 株式会社沖データ 媒体搬送装置及び画像形成装置
FR2926297B1 (fr) * 2008-01-10 2013-03-08 Centre Nat Rech Scient Molecules chimiques inhibitrices du mecanisme d'epissage pour traiter des maladies resultant d'anomalies d'epissage.
US8117648B2 (en) * 2008-02-08 2012-02-14 Intersections, Inc. Secure information storage and delivery system and method
US20140187641A1 (en) * 2012-08-23 2014-07-03 Gtx Estrogen receptor ligands and methods of use thereof
FI2440546T3 (fi) 2009-06-12 2023-03-30 Abivax Ennenaikaisen vanhenemisen ja erityisesti progerian hoitamiseen hyödyllisiä yhdisteitä
JP2011026251A (ja) 2009-07-27 2011-02-10 Kowa Co 2−アリールアミノキノリン化合物及びこれを有効成分として含有するエリスロポエチン産生促進剤
MA34385B1 (fr) 2010-06-24 2013-07-03 Takeda Pharmaceutical Composés hétérocycliques condensés comme inhibiteurs de phosphodiestérases (pdes)
EP2465502A1 (en) 2010-12-15 2012-06-20 Société Splicos Compounds useful for treating AIDS
FR2972719B1 (fr) * 2011-03-15 2013-04-12 Gaztransp Et Technigaz Bloc isolant pour la fabrication d'une paroi de cuve etanche
EP2505198A1 (en) * 2011-04-01 2012-10-03 Société Splicos Compounds for use as therapeutic agents affecting p53 expression and/or activity
EP2712862A1 (en) * 2012-09-28 2014-04-02 Splicos New anti-invasive compounds
WO2014164667A1 (en) 2013-03-11 2014-10-09 Georgetown University Dengue and west nile virus protease inhibitors
MX382692B (es) * 2013-07-05 2025-03-13 Abivax Compuestos bicíclicos útiles para el tratamiento de enfermedades causadas por retrovirus.
WO2015028989A1 (en) * 2013-09-02 2015-03-05 Actelion Pharmaceuticals Ltd Novel heterocyclic compounds as antimalarial agents
RU2628800C2 (ru) 2014-03-12 2017-08-22 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Амидные соединения, способы получения, применение в качестве средств для лечения и профилактики заболеваний, вызываемых рнк-содержащими вирусами
KR102265277B1 (ko) * 2014-04-11 2021-06-16 판옵테스 파르마 게스.엠.베.하. 바이러스 억제 화합물로서의 항-염증제
WO2016086153A2 (en) * 2014-11-26 2016-06-02 Esanex, Inc. Use of tetrahydro!ndazolylbeimzamide and tetrahydroindolylbenzamide derivatives for the treatment of human immunodeficiency virus (hiv) and acquired immune deficiency syndrome (aids)
EP3059591A1 (en) 2015-02-23 2016-08-24 Abivax Methods for screening compounds for treating or preventing a viral infection or a virus-related condition
EP3058940A1 (en) 2015-02-23 2016-08-24 Abivax Quinoline derivatives for use in the treatment or prevention of viral infection
PL3429998T3 (pl) 2016-03-18 2022-03-14 Prosynergia S.à.r.l. Sposób wytwarzania pochodnych chinolin-2-ylo-fenyloaminy oraz jej soli

Similar Documents

Publication Publication Date Title
JP2021524481A5 (enExample)
CA2916623C (en) Bicyclic compounds useful for treating diseases caused by retroviruses
JP2021524482A5 (enExample)
JP2004509113A5 (enExample)
JP2022545359A5 (enExample)
KR102905375B1 (ko) Rna 바이러스 감염을 치료하기 위한 페닐/피리딜-n-페닐/피리딜 유도체
AR035979A1 (es) Derivados de quinolina, procedimientos para su preparacion, composiciones farmaceuticas que los comprenden, y usos de dichos compuestos para la preparacion de medicament0s
JP2016523893A5 (enExample)
JP2005535586A5 (enExample)
JP2002534519A5 (enExample)
TW201014857A (en) CMET inhibitors
JP2004509118A5 (enExample)
JP2007501831A5 (enExample)
JP2021524487A5 (enExample)
JP2016516699A5 (enExample)
JP2021500332A5 (enExample)
JP2020533352A5 (enExample)
CA2568608A1 (en) Six membered amino-amide derivatives as angiogenesis inhibitors
AU2013343291B2 (en) Novel histone deacetylase inhibitors and their use in therapy
JP2017532358A5 (enExample)
JP2005528459A5 (enExample)
JP2003513066A5 (enExample)
JP2006519807A5 (enExample)
JP2018522915A5 (enExample)
EP3297991B1 (en) Novel amidoheteroaryl aroyl hydrazide ethynes